Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ligand Pharmaceuticals Incorporated

LGND Technical Analysis Summary (NASDAQ)

Analyze LGND on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

LGND●NASDAQ
HealthcareBiotechnology
$302.18
$10.14(3.47%)
U.S. Market is Open · 14:21

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

LGND Technical Analysis Summary (NASDAQ)

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bullish (RSI: 54.01)
Trend Strength:Weak (ADX: 16.11)
Volatility:Medium (ATR: 11.44)
Support/Resistance:$283.43 – $318.96 (Bollinger Bands)

Technical conditions suggest Ligand Pharmaceuticals Incorporated on the NASDAQ is awaiting a decisive move. Technical conditions suggest Ligand Pharmaceuticals Incorporated is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 54.01

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 34.48

Bearish
Momentum remains weak below midpoint.

Williams %R: -35.64

Bullish
Buying pressure building steadily.

Rate of Change (ROC): 1.17

Bullish
Steady upward momentum.

Takeaway:Ligand Pharmaceuticals Incorporated shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 2.33

Bullish
Bullish, trend momentum is strengthening.

ADX: 16.11

Weak
Weak trend, market trading sideways.

ATR (14): 11.44

Rising
Rising volatility, market activity increasing.

CCI (14): 12.40

Neutral
Neutral, no strong directional signal.

Takeaway:Ligand Pharmaceuticals Incorporated shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$318.96
Middle Band (SMA 20)
$301.19
Lower Band
$283.43
Current Position
Within Bands

Takeaway:Ligand Pharmaceuticals Incorporated trades around the middle band, reflecting balanced price action.

Keltner Channels
Upper Channel
$319.30
Middle Line (EMA 20)
$296.42
Lower Channel
$273.54
Squeeze Status
Squeeze On

Takeaway:Ligand Pharmaceuticals Incorporated trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume5.55M
Money Flow Index35.25Bearish, selling pressure outweighs inflows.
Relative Vigor Index50.52Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:LGND shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Technical indicators for Ligand Pharmaceuticals Incorporated are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: LGND) Technical Analysis FAQ